20 related articles for article (PubMed ID: 34761624)
1. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
Ebrahimi N; Manavi MS; Faghihkhorasani F; Fakhr SS; Baei FJ; Khorasani FF; Zare MM; Far NP; Rezaei-Tazangi F; Ren J; Reiter RJ; Nabavi N; Aref AR; Chen C; Ertas YN; Lu Q
Cancer Metastasis Rev; 2024 Mar; 43(1):457-479. PubMed ID: 38227149
[TBL] [Abstract][Full Text] [Related]
2. BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer.
Shu J; Wang L; Han F; Chen Y; Wang S; Luo F
Biomed Res Int; 2019; 2019():5937635. PubMed ID: 31886230
[TBL] [Abstract][Full Text] [Related]
3. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
4. BTBD7 silencing inhibited epithelial- mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma.
Yang L; Wang T; Zhang J; Wang X
Cancer Biomark; 2017 Dec; 20(4):461-468. PubMed ID: 28946551
[TBL] [Abstract][Full Text] [Related]
5. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.
Yee DS; Tang Y; Li X; Liu Z; Guo Y; Ghaffar S; McQueen P; Atreya D; Xie J; Simoneau AR; Hoang BH; Zi X
Mol Cancer; 2010 Jun; 9():162. PubMed ID: 20573255
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
8. BTBD7 accelerates the epithelial-mesenchymal transition, proliferation and invasion of prostate cancer cells.
Chen B; Liu C; Bai G; Zhu Y; Xu H
J BUON; 2021; 26(5):2111-2116. PubMed ID: 34761624
[TBL] [Abstract][Full Text] [Related]
9. The Role of BTBD7 in Normal Development and Tumor Progression.
Liu Y; Song J; Gu J; Xu S; Wang X; Liu Y
Technol Cancer Res Treat; 2023; 22():15330338231167732. PubMed ID: 37050886
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
